Cervical cancer survival in a resource-limited setting-North Central Nigeria
- PMID: 27014366
- PMCID: PMC4806480
- DOI: 10.1186/s13027-016-0062-0
Cervical cancer survival in a resource-limited setting-North Central Nigeria
Abstract
Background: Organized cervical cancer screening services are presently lacking in Nigeria contributing to late presentation and diagnosis of invasive cervical cancer cases (ICCs) at advanced stages in most gynecologic units in Nigeria. We evaluated outcomes of ICCs diagnosed at Jos University Teaching Hospital (JUTH) to better understand factors associated with cervical cancer survival in similar resource limited settings.
Methods: We performed a retrospective cohort study with a prospective follow up data to estimate time from diagnosis to mortality among women diagnosed with ICCs at JUTH. Women who were diagnosed with ICCs between January 2011 and May 2013 were followed up after initial evaluation at JUTH and subsequent referral for specialized treatment in one of the national oncology treatment centers in Nigeria. The main outcome measured was all-cause mortality rate and overall survival (OS) after diagnosis of ICC. The follow up data were updated and observations were censored March 31, 2015. The overall death rate was estimated using the total number of death events and the cumulative follow-up time from diagnosis to death. We conducted Cox proportional hazard regression to assess factors associated with death.
Results: A total of 65 histologically confirmed ICCs were followed up. The median age of the cohort was 50 years with a median parity of 7. The HIV prevalence in the cohort was 8.2 % and the majority (72.3 %) were diagnosed at advanced stages (AD) of ICC. Simple total abdominal hysterectomy (TAH) was performed in 38.9 % of patients who were diagnosed at early stage disease (ED). After a cumulative follow up of 526.17 months, 35 deaths occurred with an overall death rate of 79.8 per 100 women-years. We also found a significantly higher hazard of death in women with AD (HR = 3.3) and baseline anemia (HR = 3.0). In the subgroup of women with ED, the OS was significantly higher for those who had TAH compared to those who did not (26.5 versus 11.6 months respectively).
Conclusion: Advanced stage disease and baseline anemia were independently associated with higher death rate. Cervical cancer patients diagnosed at early stages by non-oncologic specialist in settings lacking the standard of care may benefit from improve survival with simple hysterectomy.
Keywords: Advanced disease; Anemia; Cervical cancer; North-Central Nigeria; Survival.
Figures




Similar articles
-
Outcome of HIV-associated lymphoma in a resource-limited setting of Jos, Nigeria.Infect Agent Cancer. 2017 Jun 5;12:34. doi: 10.1186/s13027-017-0144-7. eCollection 2017. Infect Agent Cancer. 2017. PMID: 28592989 Free PMC article.
-
Epidemiology and survival outcomes of HIV-associated cervical cancer in Nigeria.Infect Agent Cancer. 2023 Nov 1;18(1):68. doi: 10.1186/s13027-023-00550-7. Infect Agent Cancer. 2023. PMID: 37915091 Free PMC article.
-
Epidemiology and Survival outcomes of HIV-associated cervical cancer in Nigeria.medRxiv [Preprint]. 2023 Aug 13:2023.08.08.23293820. doi: 10.1101/2023.08.08.23293820. medRxiv. 2023. Update in: Infect Agent Cancer. 2023 Nov 1;18(1):68. doi: 10.1186/s13027-023-00550-7. PMID: 37609183 Free PMC article. Updated. Preprint.
-
High-risk human papilloma virus and cervical abnormalities in HIV-infected women with normal cervical cytology.Infect Agent Cancer. 2014 Nov 3;9(1):36. doi: 10.1186/1750-9378-9-36. eCollection 2014. Infect Agent Cancer. 2014. PMID: 25395987 Free PMC article.
-
The association between HIV infection and cervical cancer presentation and survival in Uganda.Gynecol Oncol Rep. 2019 Nov 19;31:100516. doi: 10.1016/j.gore.2019.100516. eCollection 2020 Feb. Gynecol Oncol Rep. 2019. PMID: 31886403 Free PMC article. Review.
Cited by
-
Survival Status and Predictors Among Women with Advanced Stage of Cervical Cancer.Int J Womens Health. 2024 Apr 15;16:605-617. doi: 10.2147/IJWH.S455235. eCollection 2024. Int J Womens Health. 2024. PMID: 38645983 Free PMC article.
-
Time to death from cervical cancer and predictors among cervical cancer patients in Felege Hiwot Comprehensive Specialized Hospital, North West Ethiopia: Facility-based retrospective follow-up study.PLoS One. 2022 Jun 24;17(6):e0269576. doi: 10.1371/journal.pone.0269576. eCollection 2022. PLoS One. 2022. PMID: 35749539 Free PMC article.
-
Survival of cervical cancer patients at Moi teaching and Referral Hospital, Eldoret in western Kenya.BMC Cancer. 2023 Nov 13;23(1):1104. doi: 10.1186/s12885-023-11506-w. BMC Cancer. 2023. PMID: 37957644 Free PMC article.
-
Clinical and non-clinical determinants of cervical cancer mortality: A retrospective cohort study in Lagos, Nigeria.Front Oncol. 2023 Feb 16;13:1105649. doi: 10.3389/fonc.2023.1105649. eCollection 2023. Front Oncol. 2023. PMID: 36874121 Free PMC article.
-
Cancer ecosystem assessment in West Africa: health systems gaps to prevent and control cancers in three countries: Ghana, Nigeria and Senegal.Pan Afr Med J. 2020 Mar 25;35:90. doi: 10.11604/pamj.2020.35.90.18516. eCollection 2020. Pan Afr Med J. 2020. PMID: 32636988 Free PMC article.
References
-
- Ferlay J, Soerjotmataram I, Ervik M, Dikshit R, Eser S, Mathiers C, Rebelo M, Parkin DM, Forman DB. Latest world cancer statistics. Global cancer burden rises to 14. 1 million new cases in 2012: Marked increase in breast cancers must be addressed. 2013.
-
- Parkin DM, Bray F, Ferlay J, Jemal A. Cancer in Africa 2012. Cancer Epidemiol Biomarkers Prev. 2014; doi:10.1158/1055-9965. EPI-14-0281. - PubMed
-
- Miller JW, Royalty J, Henley J, White A, Richardson LC. Breast and cervical cancers diagnosed and stage at diagnosis among women served through the National Breast and Cervical Cancer Early Detection Program. Cancer Causes Control. 2015;26(5):741–747. doi: 10.1007/s10552-015-0543-2. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources